AstraZeneca pulls cancer drug application in Europe
September 21, 2016 at 06:21 AM EDT
LONDON, Sept 21 (Reuters) - AstraZeneca has pulled an application seeking European approval to sell its experimental cancer drug cediranib in combination with chemotherapy to treat ovarian cancer because of late-stage questions raised by regulators reviewing the product.